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Introduction
Blood	 products	 transfusion	 is	 an	 essential	
procedure	in	small	animal	medicine.	Today,	blood	
transfusion	is	of	clinical	interest	for	more	species	
(dog,	 cat,	 horse,	 birds,	 ferrets)	 even	 though,	 the	
compatibility	blood	tests	are	well	represented	on	
the	market,	 it	 is	 possible	 that	 for	 some	 patients	
there	might	not	be	homologous	donors,	situations	
in	 which	 the	 clinician	 is	 tempted	 to	 submit	 to	
xenotransfusion.	 This	 documentation	 has	 been	
achieved	 by	 analyzing	 reports	 from	 renowned	
scientific	researchers	 in	veterinary	medicine	and	
bio-medical	sciences,	but	also	through	discussions	
with	specialists	in	hemotransfusion	therapy.	
We	aim	to	analyze	the	information	regarding	
blood	xenocompatibility	for	dog	to	cat,	in	order	to	
evaluate	the	benefits	and	risks	when	submitting	to	
emergency	xenotransfusion	with	canine	blood	for	
cats,	 and	 lacking	 homologous	 blood,	 superior	 in	
terms	of	compatibility.	
Xenotransfusion in recent years
Scientific	 studies	 regarding	 xenotransfusions	
from	dog	to	cat	are	recorded	since	1962	when	22	cats	
were	transfused	with	canine	blood (Hessler,	1962).	
The	pre-transfusion	tests	-	a	slide	agglutination	test	
and	an	 in	vitro	hemolysis	 test	 -	 revealed	no	signs	
of	 immediate	 incompatibilities	 and	 thus	 the	 cats	
were	 administered	 5-50	 ml	 of	 canine	 blood	 per	
animal	at	a	rate	of	2-3	ml/min,	even	though	recent	
studies	 do	 not	 recommend	 higher	 rates	 than	 20	
ml/kg	per	hour.	These	transfusions	however	were	
experimental	and	several	of	them	were	performed	
after	the	first	transfusion.	Within	4-7	days,	the	same	
agglutination	 compatibility	 tests	 were	 performed	
and	 the	 results	 were	 positive	 in	 all	 but	 one	 case	
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Abstract 
As	 it	 is	well	known,	any	 incompatible	blood	 transfusion	can	generate	adverse	 reactions	 in	 feline	patients,	
because	 cats	 naturally	 have	 plasmatic	 alloantibodies.	 Even	 so,	 recent	 scientific	 studies	 have	 shown	 that	
transfusions	with	heterologous	blood	(canine)	to	cats,	were	indeed	followed	by	mild	hemolysis	states,	in	cases	of	
severely	anemic	patients.	A	repeated	transfusion	however	will	cause	anaphylactic	shock	with	fatal	outcome.	Based	
on	the	data	we	have	studied,	we	consider	xenotransfusion,	even	though	still	 controversial,	 to	be	considered	as	
an	emergency	therapeutic	procedure	when	superior,	homologous	blood	cannot	be	acquired	for	felines.	Through	
this	review	we	hope	to	offer	clinicians	the	necessary	information	to	consider	xenotransfusion	as	an	alternative	in	
emergency	therapy,	when	this	is	rigorously	sustained	by	blood	compatibility	tests	and	when	all	other	options	have	
been	excluded	only.
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which	developed	the	antibodies	12	days	later.	The	
hemolysis	 tests	 became	 positive	 in	 14-21	 days	
post	 transfusion,	 with	 one	 case	 having	 a	 positive	
result	in	7	days	post	transfusion.	The	second	blood	
transfusion	was	performed	on	20	cats.	The	results	
revealed	 that	 4	 days	 after	 the	 first	 transfusion	
there	 was	 no	 reaction,	 however	 after	 the	 6th	 day	
they	all	developed	post	transfusion	reactions,	with	
anaphylactic	shocks	and	hemoglobinuria.	Long	term	
follow-up	 of	 the	 surviving	 cats	 was	 not	 provided	
in	 this	 study.	 Other	 two	 studies	 were	 performed	
later	 on	 in	 1968	 and	 1969,	 both	 cases	 reporting	
no	 signs	 of	 post	 transfusion	 incompatibility	 after	
the	 first	 transfusion.	 The	 study	 report	 from	1968	
had	done	pre	transfusion	tests,	a	major	crossmatch	
and	 minor	 crossmatch	 respectively.	 Out	 of	 the	
fours	cats	considered	for	the	transfusion,	2	of	them	
showed	an	incompatibility	in	the	minor	crossmatch	
test.	 None	 of	 the	 cats	 however	 exhibited	 signs	 of	
distress	 or	 post	 transfusion	 reactions	 after	 the	
first	 transfusion.	The	second	 transfusion	 that	was	
performed	7	days	after	the	first,	ended	with	fatality	
for	 the	 cat	 considered.	 The	 rest	 of	 the	 cats	 were	
transfused	a	second	time	after	1	and	2	days	with	no	
results	to	report.	The	same	study	reports	cases	of	
20	other	cats	subjected	to	canine	xenotransfusions,	
all	anemic.	No	compatibility	tests	were	performed	
however	before	or	after	the	transfusion.	Out	of	the	
total	number	of	cases	fifteen	cats	survived,	the	rest,	
the	study	states,	dying	from	the	underlying	cause	of	
the	disease	(Hessler,	1962).	Since	then,	regulations	
of	 animal’s	 rights	 prevented	 experiments	 on	
animals	with	no	imminent	reason	for	the	results.	As	
such,	since	then	there	have	been	many	case	reports	
that	 express	 a	 lack	 of	 available	 compatible	 blood	
for	cats	and	also	favorable	results	post	transfusion	
with	dog’s	blood.	In	all	the	cases	the	patient	was	in	
an	emergency	situation	with	either	no	access	to	a	
compatible	donor	or	lack	of	financial	support	from	
the	owner.	
In	2004	a	case	report	from	Australia	described	
the	transfusion	of	canine	blood	to	an	anemic	cat.	
The	blood	group	of	the	cat	was	typed	as	being	blood	
group	B	 and	 a	major	 and	minor	 crossmatch	 test	
was	performed	with	no	incompatibility	reactions.	
The	clinician	administered	an	 initial	dose	of	1ml	
intravenously	to	the	cat,	with	no	reaction.	130	ml	
were	then	transfused	over	the	course	of	48h	with	
no	acute	post	transfusion	reactions.	Although	the	
initial	response	was	favorable,	and	it	allowed	the	
veterinarians	 to	 put	 the	 cat	 under	 anesthesia,	
the	 cause	 of	 the	 anemia	 had	 been	 identified	 as	
erythroid	 leukemia	 and	 the	 patient	 was	 later	
euthanized	(Gowan,	2004).		
The	 studies	 considered	 so	 far	 came	 to	 the	
conclusion	that	cats	do	not	appear	to	have	natural	
occurring	 antibodies	 anti	 canine	 erythrocytes	
and	 as	 a	 result	 there	 were	 no	 cases	 of	 acute	
hemolytic	 reactions	 and	 the	 patients	 benefitted	
from	 the	 initial	 transfusion	 as	 it	 allowed	 the	
clinician	 to	 identify	 the	 underlying	 cause	 of	 the	
anemia.	(Bovens	and	Gruffydd-Jones,	2013).	This	
statement	 however	 has	 been	 disproved	 by	more	
recent	studies	that	have	proven	otherwise.
Another	 case	 report,	 from	 2014,	 in	 Israel,	
treated	 a	 one	 month	 old	 male	 cat	 with	 an	
apparent	 flea	 infestation	 (Weingram,	 2014).	 The	
PCV	 was	 13%	 and	 after	 fluid	 treatment	 with	
intravenous	 0.9%	 saline,	 the	 PCV	 had	 dropped	
to	 8%.	 Transfusion	 was	 thus	 deemed	 necessary,	
however	due	to	the	owners’	financial	restrictions,	
pRBCs	 could	 not	 be	 administered	 and	 such,	
xenotransfusion	 was	 elected.	 No	 crossmatch	
tests	were	 performed	 before	 the	 procedure,	 and	
10ml/kg	 of	 canine	 blood	was	 administered	 over	
the	course	of	one	hour.	Post	 transfusion	 the	PCV	
increased	 to	 21%,	 eight	 days	 post	 presentation	
rising	up	to	28%,	with	no	evidence	of	hemolysis	or	
icterus	in	the	sera.	
The	 most	 recent	 case	 report,	 from	 2016,	
in	 the	 USA	 (Euler	 et al.,	 2016),	 decided	 on	
xenotransfusion	 for	 a	 cat	 which	 had	 ingested	
anticoagulants	 rodenticide,	 and	 the	blood	 typing	
methods	 revealed	 the	 group	 B	 with	 the	 CARD	
method	 and	 AB	 with	 the	 Alvedia	 Strip	 method.	
Both	 situations	 would	 be	 dangerous	 due	 to	 the	
strong	 natural	 antibodies	 of	 the	 type	 B	 group.	
However,	 the	 apparent	 discordance	 revealed	 by	
the	 typing	 tests	 and	 the	 lack	 of	 readily	 available	
compatible	feline	pRBC	(pure	Red	Blood	Cell)	led	
to	 xenotransfusion	 with	 64	 ml	 of	 canine	 pRBC,	
DEA	1	negative,	over	 the	course	of	3-4	h.	Within	
one	 hour	 of	 the	 first	 transfusion	 the	 cat	 started	
eating	and	grooming	itself.	The	levels	of	the	cat’s	
PCV	though	at	21%	after	the	transfusion,	dropped	
to	 14%	 four	 days	 later.	 The	 patient	 however	
was	 doing	 clinically	 well,	 showing	 no	 sign	 of	
further	 bleeding	 and	 not	 needing	 any	 further	
tests.	 The	 second	 case	 this	 report	 provides	 is	 a	
cat	 with	 severe	 non-regenerative	 normocytic-
normochromic	 anemia,	 a	 PCV	 of	 6%.	 The	 cat	
was	 typed	with	 the	 CARD	method	 as	 being	 type	
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A	blood	group,	and	was	subsequently	 transfused	
with	1ml	of	blood	from	a	known	type	A	donor.	The	
post	 transfusion	reactions	was	severe	with	acute	
bradycardia,	open	mouth	breathing,	hypothermia	
and	 collapse.	 A	major	 crossmatch	 test	 was	 later	
performed	 with	 2	 other	 type	 A	 donors	 and	 the	
results	 were	 strongly	 incompatible.	 Repeated	
CARD	tests	were	performed	and	the	cat	remained	
typed	 A.	 Similar	 case	 reports	 revealed	 major	
cross	 matching	 type	 A	 cats	 to	 prove	 somewhat	
unreliable	 and	 it	 led	 to	 identifying	 new	 cat	
erythrocyte	 antigens	 (Weinstein	et al.,	 2007).	 As	
it	was,	 the	situation	proving	to	be	an	emergency,	
the	 staff	 resolved	 to	 xenotransfusion	 12	 hours	
after	the	initial	reaction	with	60	ml	of	fresh	whole	
blood	 from	a	canine	donor	DEA	1-,	DEA	4+,	DEA	
7+.	Even	though	the	PCV	went	up	to	22%	with	no	
overt	clinical	reaction,	the	plasma	was	hemolyzed	
after	four	days	and	the	value	fell	down	to	7%,	with	
open	mouth	breathing,	bradycardia	and	collapse.	
As	the	anemia	still	was	not	resolved,	a	littermate	
was	found	and	after	deemed	compatible	through	
major	and	minor	crossmatch,	a	transfusion	of	60	
ml	 whole	 blood	 was	 performed.	 The	 PCV	 rose	
to	15%	and	 the	 cat	was	discharged	after	7	days,	
without	identifying	the	cause	of	the	anemia	or	the	
cause	of	 the	post	 transfusion	reactions	 following	
the	 administration	 of	 1ml	 of	 whole	 blood	 from	
same	type	blood	group.	The	study	expresses	how	
errors	can	occur	during	typing	either	due	to	human	
errors	as	well	as	because	of	the	limitations	of	the	
typing	 kits.	 Such	 errors	 and	 lack	 of	 sensitivity	
in	 the	 CARD	 and	 Alvedia	 Strip	 tests	 have	 been	
previously	 reported	 (Seth	 and	 Jackson,	 2011;	
Davidow,	2013).	Moreover	when	in	both	cases	the	
typing	method	issued	errors,	the	clinicians	chose	
the	 canine	blood	as	an	alternative	 to	 transfusing	
the	 cat	 with	 incompatible	 blood.	 Furthermore	
most	 canine	 plasmas	 caused	 agglutination	
reactions	 with	 feline	 RBC,	 however,	 the	 first	 cat	
showed	 that	 it	 benefitted	 from	 the	 plasmatic	
components	 of	 the	 canine	 blood,	 since	 pRBC	
does	 carry	 some	 plasma,	 up	 to	 10%.	 However,	
the	 potential	 benefits	 of	 xenotransfusing	 cats	
with	 canine	 plasma	 have	 not	 yet	 been	 explored.	
The	 case	 report	 highlights	 inconsistency	 in	 the	
presence	 of	 natural	 cat	 alloantibodies	 against	
canine	 erythrocytes.	 The	 studies	 considered	 for	
this	review	-	 that	have	performed	crossmatching	
tests	between	cats	and	dogs	-	revealed	either	that	
they	 were	 all	 incompatible	 or	 on	 the	 contrary,	
nearly	all	compatible.	
Summary and Discussions
In	 the	 case	 reports	 from	 the	 1960s	 the	
pre	 transfusion	 compatibility	 tests	 used	 were	
not	 the	 gold	 standard.	 The	 blood	 typing	 of	 the	
cats	 considered	 was	 not	 performed	 and	 the	
agglutination	 and	 hemolysis	 tests	 performed	
revealed	no	initial	incompatibility	between	feline	
and	canine	RBCs.	However,	incompatibilities	were	
detected	 during	 the	 minor	 crossmatching	 tests	
which	were	deemed	 to	have	 little	 significance	 in	
clinics	as	the	volume	of	the	donor	plasma	is	usually	
small.	 None	 of	 the	 feline	 patients	 considered	 in	
these	 case	 reports	 exhibited	 any	 acute	 reactions	
after	 the	 first	 transfusions,	 leading	 the	 authors	
to	 believe	 that	 cats	 have	 no	 natural	 occurring	
alloantibodies	against	canine	erythrocyte	antigens	
(Kerr,	 2002).	 The	 study	 from	 2016	 however	
although	in	both	of	the	cases	there	were	no	initial	
post	transfusion	reactions,	concluded	that	because	
of	the	minor	crossmatch	tests	(Thengchaisri	et al.,	
2017),	which	 are	 positive	 in	 some	 cases,	 certain	
felines	 do	 have	 natural	 occurring	 alloantibodies	
against	dog’s	RBCs.	
All	 of	 the	 cases	 reviewed	 revealed	 however	
in	vivo	 that	 the	 first	 transfusion	did	not	produce	
acute	 immediate	 reactions,	 but	 that	 the	 canine	
transfused	erythrocytes	were	short	lived,	4-7	days.	
In	 delayed	 hemolytic	 transfusion	 reactions,	 the	
newly-formed	antibodies	adhere	to	the	transfused	
red	cells,	which	are	prematurely	removed	from	the	
circulation	and	undergo	extravascular	hemolysis.	
The	experimental	 trials	revealed	the	results	 fatal	
of	 a	 second	 transfusion	 after	 the	 cat	 developed	
antibodies	anti	dog	erythrocyte	antigens.	
The	 decrease	 in	 the	 PCV	 during	 4-6	 days	 is	
a	 reason	 for	 concern	 unless	 the	 cat’s	 organism	
developed	 a	 significant	 regenerative	 response	 in	
the	meantime.	The	peripheral	blood	tests,	4	days	
into	the	anemia	may	not	detect	the	newly	formed	
RBC.	The	process	of	creating	new	red	blood	cells,	
takes	up	to	4	days	(Day	et al.,	2000;	Hourani	et al.,	
2017).  
Conclusions
Xenotransfusions	 remain	 controversial	 in	
their	use	and	it	is	not	recommended	as	a	standard	
or	 routine	 procedure	 in	 veterinary	 medicine.	
The	transfusion	of	a	cat	with	canine	blood	is	on	a	
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short	 term	and	useful	 for	doctors	 to	 identify	 the	
underlying	 cause	 of	 the	 anemia.	 Also,	 there	 are	
regions	where	the	prevailing	blood	group	is	type	
B	or	AB	and	 finding	a	 suitable	donor	 is	not	only	
difficult	 but	 financially	 restricting.	 In	 such	 cases,	
with	the	approval	of	the	owners	xenotransfusion	
was	 deemed	 the	 best	 solution	 as	 the	 patient’s	
clinical	signs	showed	no	improvement	otherwise.	
Other	benefits	 to	 xenotransfusions	would	be	 the	
larger	quantity	of	blood	that	can	be	obtained	from	a	
dog	and	also,	the	lack	of	transmittable	viruses	that	
are	 feline	 specific	 providing	 a	 safer	 transfusion.	
Moreover,	 the	canine	plasma	 transfusion,	 though	
less	 researched	offer	 coagulating	 factors	 for	 cats	
with	 rodenticide	 substances	 intoxication.	 Such	
transfusions	 are	 already	 explored	 in	 human	
medicine	where	heterologous	porcine	coagulation	
factors	 are	 used	 to	 help	 hemophilic	 human	
patients.	In	regards	to	this	subject,	more	and	more	
researchers	are	looking	into	xenotransfusion	as	a	
way	to	help	the	supply	of	human	compatible	blood	
from	pig	red	blood	cells	(Borel,	2003;	Roux,	2007).	
As	a	conclusion,	based	on	the	reviewed	cases,	
xenotransfusions	 should	 not	 be	 used	 unless	
homologous	 blood	 cannot	 be	 obtained,	 as	 the	
post	 transfusion	 reactions	 cannot	 be	 accurately	
predicted	 and	 may	 distress	 an	 already	 depleted	
organism,	 as	 a	 result	 of	 anemia.	 Heterologous	
blood	 should	 be	 used	 only	 with	 the	 accord	 of	
the	 owners	 after	 briefing	 them	 on	 the	 possible	
outcomes.	If	a	transfusion	of	canine	blood	to	feline	
is	decided,	a	major	and	minor	crossmatch	test	 is	
most	highly	recommended	(Hourani	et al.,	2017)	
as	 it	 reduces	 the	 chances	 of	 immediate	 acute	
reactions.	Overall,	xenotransfusions	may	be	a	gate	
to	healing	a	patient	in	an	emergency	situation	but	
the	 lack	 of	 enough	 research	 in	 regards	 to	 blood	
groups	in	animals	and	a	lack	of	consistency	in	the	
post	 transfusion	results	with	heterologous	blood	
puts	this	therapy	in	a	lasting	controversy.	
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